1mqb: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /> <applet load="1mqb" size="450" color="white" frame="true" align="right" spinBox="true" caption="1mqb, resolution 2.30Å" /> '''Crystal Structure o...
 
No edit summary
Line 1: Line 1:
[[Image:1mqb.gif|left|200px]]<br />
[[Image:1mqb.gif|left|200px]]<br /><applet load="1mqb" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1mqb" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1mqb, resolution 2.30&Aring;" />
caption="1mqb, resolution 2.30&Aring;" />
'''Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase'''<br />
'''Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase'''<br />


==Overview==
==Overview==
Protein kinases are important drug targets in human cancers, inflammation, and metabolic diseases. This report presents the structures of kinase, domains for three cancer-associated protein kinases: ephrin receptor A2, (EphA2), focal adhesion kinase (FAK), and Aurora-A. The expression, profiles of EphA2, FAK, and Aurora-A in carcinomas suggest that inhibitors, of these kinases may have inherent potential as therapeutic agents. The, structures were determined from crystals grown in nanovolume droplets, which produced high-resolution diffraction data at 1.7, 1.9, and 2.3 A for, FAK, Aurora-A, and EphA2, respectively. The FAK and Aurora-A structures, are the first determined within two unique subfamilies of human kinases, and all three structures provide new insights into kinase regulation and, the design of selective inhibitors.
Protein kinases are important drug targets in human cancers, inflammation, and metabolic diseases. This report presents the structures of kinase domains for three cancer-associated protein kinases: ephrin receptor A2 (EphA2), focal adhesion kinase (FAK), and Aurora-A. The expression profiles of EphA2, FAK, and Aurora-A in carcinomas suggest that inhibitors of these kinases may have inherent potential as therapeutic agents. The structures were determined from crystals grown in nanovolume droplets, which produced high-resolution diffraction data at 1.7, 1.9, and 2.3 A for FAK, Aurora-A, and EphA2, respectively. The FAK and Aurora-A structures are the first determined within two unique subfamilies of human kinases, and all three structures provide new insights into kinase regulation and the design of selective inhibitors.


==About this Structure==
==About this Structure==
1MQB is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ANP as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1MQB OCA].  
1MQB is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ANP:'>ANP</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Transferase Transferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.10.1 and 2.7.10.2 2.7.10.1 and 2.7.10.2] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MQB OCA].  


==Reference==
==Reference==
Line 15: Line 14:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Transferase]]
[[Category: Transferase]]
[[Category: Cronin, C.N.]]
[[Category: Cronin, C N.]]
[[Category: Knuth, M.W.]]
[[Category: Knuth, M W.]]
[[Category: McRee, D.E.]]
[[Category: McRee, D E.]]
[[Category: Nelson, C.]]
[[Category: Nelson, C.]]
[[Category: Nowakowski, J.]]
[[Category: Nowakowski, J.]]
[[Category: Pavletich, N.]]
[[Category: Pavletich, N.]]
[[Category: Rogers, J.]]
[[Category: Rogers, J.]]
[[Category: Sang, B.C.]]
[[Category: Sang, B C.]]
[[Category: Scheibe, D.N.]]
[[Category: Scheibe, D N.]]
[[Category: Swanson, R.V.]]
[[Category: Swanson, R V.]]
[[Category: Thompson, D.A.]]
[[Category: Thompson, D A.]]
[[Category: ANP]]
[[Category: ANP]]
[[Category: tyrosine protein kinase]]
[[Category: tyrosine protein kinase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:14:09 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:57:54 2008''

Revision as of 14:57, 21 February 2008

File:1mqb.gif


1mqb, resolution 2.30Å

Drag the structure with the mouse to rotate

Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase

OverviewOverview

Protein kinases are important drug targets in human cancers, inflammation, and metabolic diseases. This report presents the structures of kinase domains for three cancer-associated protein kinases: ephrin receptor A2 (EphA2), focal adhesion kinase (FAK), and Aurora-A. The expression profiles of EphA2, FAK, and Aurora-A in carcinomas suggest that inhibitors of these kinases may have inherent potential as therapeutic agents. The structures were determined from crystals grown in nanovolume droplets, which produced high-resolution diffraction data at 1.7, 1.9, and 2.3 A for FAK, Aurora-A, and EphA2, respectively. The FAK and Aurora-A structures are the first determined within two unique subfamilies of human kinases, and all three structures provide new insights into kinase regulation and the design of selective inhibitors.

About this StructureAbout this Structure

1MQB is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Transferase, with EC number and 2.7.10.2 2.7.10.1 and 2.7.10.2 Full crystallographic information is available from OCA.

ReferenceReference

Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography., Nowakowski J, Cronin CN, McRee DE, Knuth MW, Nelson CG, Pavletich NP, Rogers J, Sang BC, Scheibe DN, Swanson RV, Thompson DA, Structure. 2002 Dec;10(12):1659-67. PMID:12467573

Page seeded by OCA on Thu Feb 21 13:57:54 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA